Clinical and Pathological Significance of Autoantibodies to Erythropoietin Receptor in Type 2 Diabetic Patients With CKD

Clinical and Pathological Significance of Autoantibodies to Erythropoietin Receptor in Type 2 Diabetic Patients With CKD

We examined the impact of autoantibodies on the erythropoietin receptor (EPOR) in type 2 diabetic patients with chronic kidney disease (CKD). Methods: A total of 112 Japanese patients with type 2 diabetes who had CKD were enrolled in this study and followed for a mean of 45 months. Sera from these p...

Full description

Bibliographic Details
Main Authors: Akinori Hara, Kengo Furuichi, Akihiko Koshino, Haruka Yasuda, Trang Thi Thu Tran, Yasunori Iwata, Norihiko Sakai, Miho Shimizu, Shuichi Kaneko, Hiroyuki Nakamura, Takashi Wada
Format: Article
Language:English
Published: Elsevier 2018-01-01
Series:Kidney International Reports
Subjects:
autoantibodies
diabetic nephropathy
erythropoietin receptor
prognosis
risk factor
Online Access:http://www.sciencedirect.com/science/article/pii/S2468024917303777

Internet

http://www.sciencedirect.com/science/article/pii/S2468024917303777

Similar Items